Vaxcyte Inc. (PCVX): Price and Financial Metrics Recent IPO


Vaxcyte Inc. (PCVX) Recent IPO

Today's Latest Price: $34.60 USD

0.29 (-0.83%)

Updated Nov 24 4:00pm

Add PCVX to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 240 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

PCVX Stock Price Chart Interactive Chart >

Price chart for PCVX

PCVX Price/Volume Stats

Current price $34.60 52-week high $58.47
Prev. close $34.89 52-week low $17.80
Day low $34.32 Volume 424,600
Day high $35.86 Avg. volume 201,484
50-day MA $43.69 Dividend yield N/A
200-day MA $0.00 Market Cap 1.76B

Vaxcyte Inc. (PCVX) Company Bio


Vaxcyte, Inc. engages in development of vaccines for infectious diseases. It focuses on conjugate vaccines and protein-based vaccines developed through Sutro Biopharma's Xpress CF Platform, a cell-free protein synthesis technology. The company was founded by Grant E. Pickering, Ashish Khanna and Jeff Fairman on November 27, 2013 and is headquartered in San Francisco, CA.


PCVX Latest News Stream


Event/Time News Detail
Loading, please wait...

PCVX Latest Social Stream


Loading social stream, please wait...

View Full PCVX Social Stream

Latest PCVX News From Around the Web

Below are the latest news stories about Vaxcyte Inc that investors may wish to consider to help them evaluate PCVX as an investment opportunity.

Vaxcyte prices IPO at $16

Vaxcyte (PCVX) has priced its IPO of 15,625,000 common shares at $16.00/share, for expected gross proceeds of $250M.Underwriters' over-allotment is an additional 2,343,750 shares.Trading kicks off today.Closing date is June 16....

Seeking Alpha | June 12, 2020

Vaxcyte Begins U.S. IPO Effort

Quick Take Vaxcyte (PCVX) has filed to raise $100 million in an IPO of its common shares, according to an S-1 registration statement. The firm is developing a pipeline of pneumococcal (pneumonia, bacteremia and meningitis) vaccine targets. PCVX is still at the ultra early pre-clinical stage for all of its...

Donovan Jones | May 29, 2020

Read More 'PCVX' Stories Here

PCVX Price Returns

1-mo -17.81%
3-mo -23.09%
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
YTD N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.7043 seconds.